$NHC
NATIONAL HEALTHCARE CORP

2016 Q2 Form 10-Q Financial Statement

#000104733516000243 Filed on August 04, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $227.8M $224.9M
YoY Change 1.27% 3.85%
Cost Of Revenue $135.1M $131.9M
YoY Change 2.43% 5.02%
Gross Profit $92.70M $93.00M
YoY Change -0.32% 2.31%
Gross Profit Margin 40.7% 41.35%
Selling, General & Admin $10.30M $10.00M
YoY Change 3.0% 1.01%
% of Gross Profit 11.11% 10.75%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.400M $9.300M
YoY Change 1.08% 8.14%
% of Gross Profit 10.14% 10.0%
Operating Expenses $77.10M $76.70M
YoY Change 0.52% 3.23%
Operating Profit $14.64M $15.71M
YoY Change -6.78% -2.34%
Interest Expense $939.0K $598.0K
YoY Change 57.02% -83.84%
% of Operating Profit 6.41% 3.81%
Other Income/Expense, Net $4.925M $4.130M
YoY Change 19.25% -3.53%
Pretax Income $19.57M $19.84M
YoY Change -1.36% -2.76%
Income Tax $7.700M $7.478M
% Of Pretax Income 39.35% 37.7%
Net Earnings $11.87M $12.36M
YoY Change -3.98% -1.22%
Net Earnings / Revenue 5.21% 5.49%
Basic Earnings Per Share $0.78 $0.74
Diluted Earnings Per Share $0.78 $0.71
COMMON SHARES
Basic Shares Outstanding 15.27M 13.77M
Diluted Shares Outstanding 15.29M 14.38M

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $179.3M $189.4M
YoY Change -5.33% -2.07%
Cash & Equivalents $37.54M $71.50M
Short-Term Investments $141.8M $117.9M
Other Short-Term Assets $30.70M $29.60M
YoY Change 3.72% 10.45%
Inventory $7.137M $7.300M
Prepaid Expenses
Receivables $77.23M $78.00M
Other Receivables $2.900M $3.900M
Total Short-Term Assets $297.3M $308.1M
YoY Change -3.51% -0.93%
LONG-TERM ASSETS
Property, Plant & Equipment $553.3M $519.6M
YoY Change 6.49% 3.44%
Goodwill $17.60M
YoY Change
Intangibles
YoY Change
Long-Term Investments $36.00M $35.10M
YoY Change 2.56% 1.74%
Other Assets $237.0M $180.1M
YoY Change 31.57% 8.43%
Total Long-Term Assets $790.3M $765.5M
YoY Change 3.24% 4.35%
TOTAL ASSETS
Total Short-Term Assets $297.3M $308.1M
Total Long-Term Assets $790.3M $765.5M
Total Assets $1.088B $1.074B
YoY Change 1.3% 2.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.80M $17.10M
YoY Change 27.49% 1.18%
Accrued Expenses $77.60M $75.60M
YoY Change 2.65% 12.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.400M $3.200M
YoY Change 6.25% 6.67%
Total Short-Term Liabilities $140.8M $171.0M
YoY Change -17.64% 6.88%
LONG-TERM LIABILITIES
Long-Term Debt $120.0M $41.90M
YoY Change 186.4% -7.1%
Other Long-Term Liabilities $17.37M $118.2M
YoY Change -85.31% -3.67%
Total Long-Term Liabilities $137.4M $160.1M
YoY Change -14.2% -4.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $140.8M $171.0M
Total Long-Term Liabilities $137.4M $160.1M
Total Liabilities $278.2M $331.0M
YoY Change -15.95% 0.98%
SHAREHOLDERS EQUITY
Retained Earnings $380.6M
YoY Change
Common Stock $153.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $671.5M $742.6M
YoY Change
Total Liabilities & Shareholders Equity $1.088B $1.074B
YoY Change 1.3% 2.78%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income $11.87M $12.36M
YoY Change -3.98% -1.22%
Depreciation, Depletion And Amortization $9.400M $9.300M
YoY Change 1.08% 8.14%
Cash From Operating Activities $22.10M $15.80M
YoY Change 39.87% 32.77%
INVESTING ACTIVITIES
Capital Expenditures -$22.70M -$10.40M
YoY Change 118.27% -24.09%
Acquisitions
YoY Change
Other Investing Activities -$2.600M -$5.000M
YoY Change -48.0% -725.0%
Cash From Investing Activities -$25.30M -$15.40M
YoY Change 64.29% 20.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.300M -7.000M
YoY Change -10.0% -4.11%
NET CHANGE
Cash From Operating Activities 22.10M 15.80M
Cash From Investing Activities -25.30M -15.40M
Cash From Financing Activities -6.300M -7.000M
Net Change In Cash -9.500M -6.600M
YoY Change 43.94% -19.51%
FREE CASH FLOW
Cash From Operating Activities $22.10M $15.80M
Capital Expenditures -$22.70M -$10.40M
Free Cash Flow $44.80M $26.20M
YoY Change 70.99% 2.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 nhc Number Of Skilled Nursing Centers
NumberOfSkilledNursingCenters
74
nhc Annual Excess Coverage
AnnualExcessCoverage
7500000
nhc Annual Excess Coverage
AnnualExcessCoverage
9000000
nhc Annual Excess Coverage
AnnualExcessCoverage
4000000
nhc Annual Excess Coverage
AnnualExcessCoverage
9000000
nhc Direct Business Coverage Statutory Limits
DirectBusinessCoverageStatutoryLimits
1000000
CY2016Q2 nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
1901000
CY2015Q2 nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
1629000
nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
3762000
nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
3505000
nhc Increase Decrease In Due To Third Party Payors
IncreaseDecreaseInDueToThirdPartyPayors
1756000
nhc Increase Decrease In Due To Third Party Payors
IncreaseDecreaseInDueToThirdPartyPayors
2526000
CY2016Q2 nhc Number Of Assisted Living Facilities
NumberOfAssistedLivingFacilities
21
CY2016Q2 nhc Number Of Beds
NumberOfBeds
9390
CY2016Q2 nhc Number Of Homecare Programs
NumberOfHomecarePrograms
36
CY2016Q2 nhc Number Of Independent Living Facilities
NumberOfIndependentLivingFacilities
5
CY2016Q2 nhc Number Of Nursing Facilities Under Medicaid Cost Report Audits
NumberOfNursingFacilitiesUnderMedicaidCostReportAudits
11
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
389498
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
480275
CY2015Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
3440000
CY2016Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
21803000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
209469000
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
342000
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-1134000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1132000
nhc Proceeds Payments Tax Benefit Expense From Stockbased Compensation
ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation
-1134000
nhc Proceeds Payments Tax Benefit Expense From Stockbased Compensation
ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation
342000
CY2015Q2 nhc Stock Repurchase Program Number Of Plans
StockRepurchaseProgramNumberOfPlans
2
CY2016Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
18410000
CY2015Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
16654000
CY2016Q2 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
3440000
CY2015Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
20128000
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
77228000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
84095000
CY2016Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
50005000
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
65338000
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
357979000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
339241000
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
71897000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
53364000
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
218896000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
494000
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
208000
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
654000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
494000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1132000
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7336000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5583000
CY2016Q2 us-gaap Assets
Assets
1087566000
CY2015Q4 us-gaap Assets
Assets
1045329000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
297278000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
278942000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
23291000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
43936000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
23273000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
173060000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
169866000
CY2016Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
169870000
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
171174000
CY2016Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
314816000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
286034000
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
115280000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
86921000
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
510000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2237000
CY2016Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
200046000
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
201350000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
55279000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
71442000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
56977000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
70223000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
70519000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
74747000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
71159000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
74671000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
995000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
1694000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
988000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
1699000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
43077000
CY2016Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3378000
CY2015Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3279000
CY2016Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
28515000
CY2015Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
30228000
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
39867000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37543000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71500000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-665000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1733000
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
5200000
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
5200000
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
5200000
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
5200000
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
5200000
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
13867000
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
7974000
CY2016Q2 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
31893000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38208000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69767000
CY2015Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.85
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.74
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15279239
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15000616
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15279239
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15000616
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
153000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
150000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22841000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
585000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
44098000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16107000
CY2016Q2 us-gaap Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount
ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount
3440000
CY2015Q4 us-gaap Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount
ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount
3440000
CY2016Q2 us-gaap Costs And Expenses
CostsAndExpenses
213127000
CY2015Q2 us-gaap Costs And Expenses
CostsAndExpenses
209196000
us-gaap Costs And Expenses
CostsAndExpenses
425091000
us-gaap Costs And Expenses
CostsAndExpenses
414167000
CY2016Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4705000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3315000
CY2016Q2 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
20406000
CY2015Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
9096000
CY2016Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8213000
CY2015Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8451000
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9495000
CY2015Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9236000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
18849000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
18169000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18849000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18169000
us-gaap Dividends Common Stock
DividendsCommonStock
10534000
us-gaap Dividends Common Stock
DividendsCommonStock
12981000
CY2016Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
6876000
CY2015Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
5996000
CY2016Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
CY2015Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2167000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
us-gaap Dividends Preferred Stock
DividendsPreferredStock
4335000
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.54
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.48
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.394
CY2015Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.377
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.391
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.383
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5635000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4749000
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
540000
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
421000
CY2016Q2 us-gaap Goodwill
Goodwill
17600000
CY2015Q4 us-gaap Goodwill
Goodwill
17600000
CY2016Q2 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
11281000
CY2015Q2 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
10469000
CY2015Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
214433000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
434593000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
426494000
CY2016Q2 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
227768000
CY2015Q2 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
224902000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
457356000
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
22763000
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
20815000
CY2016Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
216487000
CY2016Q2 us-gaap Inventory Net
InventoryNet
7137000
CY2015Q4 us-gaap Inventory Net
InventoryNet
7568000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15894000
CY2016Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
915000
CY2015Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3203000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1675000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1244000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3072000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2877000
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-15333000
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-10849000
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-34000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
447309000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
19566000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
19836000
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
41963000
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
41494000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3120000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2386000
CY2016Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1615000
CY2015Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1268000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7700000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7478000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16398000
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-203000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
244000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
4869000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1390000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1533000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
216000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
494000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-2288000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-4727000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-431000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
146000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
609000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
3295000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1073000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1386000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
967000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
699000
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-4748000
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-5738000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
10342000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
5701000
CY2016Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
CY2015Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
450486
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
97137
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
410441
CY2016Q2 us-gaap Interest Expense
InterestExpense
939000
CY2015Q2 us-gaap Interest Expense
InterestExpense
598000
us-gaap Interest Expense
InterestExpense
1893000
us-gaap Interest Expense
InterestExpense
1188000
CY2016Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1409000
CY2015Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1233000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2816000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2461000
CY2016Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
36005000
CY2015Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
37683000
CY2016Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
135068000
CY2015Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
131914000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
265088000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
257630000
CY2016Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
10319000
CY2015Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
9981000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
20646000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
19966000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1087566000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1045329000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
140829000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
150656000
CY2016Q2 us-gaap Long Term Debt
LongTermDebt
120000000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
120000000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
110000000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
10000000
CY2016Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
120000000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
120000000
CY2016Q2 us-gaap Malpractice Loss Contingency Number Of Claims
MalpracticeLossContingencyNumberOfClaims
36
CY2016Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
141756000
CY2015Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
116168000
CY2016Q2 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
13220000
CY2015Q4 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
18276000
CY2016Q2 us-gaap Marketable Securities Restricted Noncurrent
MarketableSecuritiesRestrictedNoncurrent
159840000
CY2015Q4 us-gaap Marketable Securities Restricted Noncurrent
MarketableSecuritiesRestrictedNoncurrent
151590000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4597000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9147000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32154000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29296000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
36086000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40176000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
11866000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
12358000
us-gaap Net Income Loss
NetIncomeLoss
25565000
us-gaap Net Income Loss
NetIncomeLoss
25600000
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11866000
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10191000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
25565000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
21265000
CY2016Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
1977000
CY2015Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
460000
CY2016Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
12970000
CY2015Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
12704000
CY2016Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
10
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
14641000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15706000
us-gaap Operating Income Loss
OperatingIncomeLoss
32265000
us-gaap Operating Income Loss
OperatingIncomeLoss
33142000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
364850000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
34200000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
34200000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
34200000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
34200000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
34200000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
193850000
CY2016Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
9831000
CY2015Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
9865000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
236964000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230341000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-9493000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
18533000
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10975000
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-11773000
CY2016Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
261000
CY2015Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
80000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
540000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
421000
CY2016Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
6887000
CY2015Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-7379000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
11554000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-6013000
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
18123000
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-19072000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
30627000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-15085000
CY2016Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
57306000
CY2015Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
57467000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
118615000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
117214000
CY2016Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12773000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12192000
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17367000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16294000
CY2016Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4925000
CY2015Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4130000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
9698000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
8352000
CY2016Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
11281000
CY2015Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
10469000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
22763000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
20815000
us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2015 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12101000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9667000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
4335000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
904000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
323000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
2144000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
4237000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36127000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23046000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
23852000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
35952000
CY2016Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
CY2015Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2167000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
4335000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2171000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
428000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
228000
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3138000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10070000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5743000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
25697000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
28296000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
25697000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
28296000
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
911303000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
875287000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
553324000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
536046000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3795000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3763000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
540000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
421000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
1614000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
1521000
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
14364000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8793000
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2336000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2313000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
380597000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
368013000
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">D</div><div style="display: inline; font-style: italic;">eferred Revenue </div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"></div></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Deferred revenue includes the deferred gain on the sale of assets to National Health Corporation (&#x201c;National&#x201d;), the non-refundable portion</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> (10%) of CCRC entrance fees being amortized over the remaining life expectancies of the residents, and premiums received within our workers&#x2019; compensation and professional liability companies that are not yet earned. </div></div></div></div></div></div></div></div>
CY2016Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
98514000
CY2015Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
98508000
CY2016Q2 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
27584000
CY2015Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
27069000
CY2016Q2 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
70930000
CY2015Q4 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
71439000
us-gaap Share Based Compensation
ShareBasedCompensation
494000
us-gaap Share Based Compensation
ShareBasedCompensation
1132000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0308
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0273
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.158
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.165
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0088
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0071
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
185459
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
55.15
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
656
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
46.69
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
56210
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
57120
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1816000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
954678
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
621390
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
197579
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.92
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.15
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
55.55
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
47.06
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
46.81
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
61.47
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
62.53
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y73D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y73D
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1778000
CY2016Q2 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
1204000
CY2016Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13768000
CY2016Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
3599000
CY2016Q2 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
190000
CY2015Q2 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
121000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5743000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10070000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
734148000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
742603000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
630996000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
671543000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
365000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
330000
CY2016Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
5831000
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Estimates and Assumptions</div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and could cause our reported net income to vary significantly from period to period.</div></div></div></div></div></div></div></div>
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15289104
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14381746
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15212275
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14336027
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15266559
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13772873
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15091732
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13767248

Files In Submission

Name View Source Status
0001047335-16-000243-index-headers.html Edgar Link pending
0001047335-16-000243-index.html Edgar Link pending
0001047335-16-000243.txt Edgar Link pending
0001047335-16-000243-xbrl.zip Edgar Link pending
exhibit311adams.htm Edgar Link pending
exhibit312daniel.htm Edgar Link pending
exhibit32nhc.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nhc-20160630.xml Edgar Link completed
nhc-20160630.xsd Edgar Link pending
nhc-20160630_cal.xml Edgar Link unprocessable
nhc-20160630_def.xml Edgar Link unprocessable
nhc-20160630_lab.xml Edgar Link unprocessable
nhc-20160630_pre.xml Edgar Link unprocessable
nhcjune2016form10q.htm Edgar Link pending
nhcjune2016form10q001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending